Ablation Technology Market Size, Share & Trends by Technology (RF, Pulse Field, Microwave, Laser, Electrical, Ultrasound, Cryo), Product (Generator, Electrode, Probe), Application (CV, Cancer, Pain, Ortho, Cosmetics), Enduser (Hospital, ASC) & Region Global Forecasts to 2029
Ablation Technology Market Size, Share & Trends
The global ablation technology market is projected to reach USD 9.62 billion by 2029 from USD 6.11 billion in 2024, at a CAGR of 9.5% from 2024 to 2029. The drivers for this market include expanding access to healthcare services, an increasing preference for minimally invasive treatments, and the use of ablation procedures in expanded application fields that fuel the ablation technology market growth. Additionally, factors such as a growing number of public campaigns to increase awareness related to early detection, a rise in global healthcare expenditure, and supportive reimbursement policies further contribute to the growth of the ablation technology market. The ablation technology market has experienced a surge on the global level due to lucrative opportunities offered by emerging countries such as India and China. Furthermore, factors such as the expansion of the private healthcare sector and increasing patient population drive the adoption of ablation solutions in the end user facilities.
Ablation Technology Market Trends
To know about the assumptions considered for the study, Request for Free Sample Report
Ablation Technology Market: Market Dynamics
Driver: Emerging ablation technologies
Pulse-field ablation (PFA) is a potentially effective technique for treating cardiac diseases. This non-thermal technique offers a tissue selectivity feature and protects neighboring tissues from harm. PFA for arrhythmias has produced encouraging findings in most preclinical and clinical studies. Additionally, growing R&D expenditure, promoting clinical trials, and recently approved products have increased the market need for this technology. In 2024, Bio Sense Webster, a division of Johnson & Johnson (US), announced that VARIPULSE had received European CE approval for using pulsed-field ablation to treat symptomatic drug-refractory recurrent paroxysmal atrial fibrillation.
Restraint: Rigorous regulatory framework
The US FDA classifies some ablation devices in Class III and the majority in Class II. Class II devices are subjected to control requirements, extended regulatory procedures, and general control requirements. Additional testing, evaluation, and labeling specifications are measures considered in the regulatory framework, which ultimately enhances the time and financial requirements for the product creation and marketing. The phases of the regulatory process can take long waiting periods, particularly concerning Class II devices with notable limitations; this may hamper innovation, and patients might not be promptly presented with potentially life-saving advances.
Opportunity: Growth potential in emerging economies
Increasing healthcare spending in emerging economies such as China, India, Brazil, and Mexico is expected to profitably present the ablation technology market. For example, almost 50% of the world's cancer patients live in emerging economies, as per GLOBOCAN 2020 data. Rising government initiatives to improve payment coverage and healthcare services support the rising use of ablation systems. The market for ablation solutions in emerging economies is anticipated to be further driven by the rise in per capita healthcare expenditure and improved access to healthcare in emerging economies.
Challenge: Therapeutic challenges and hazardous effects of ablation
Market participants have difficulty proving the effectiveness of ablation-based therapies despite their advantages. During treating cardiovascular diseases, catheter ablation may cause weariness, bleeding, infection, and damage to the nearby blood vessels. Thus, doctors may recommend medicine instead of cardiac ablation treatment to minimize adverse effects. Gases such as nitrogen, nitrous oxide, argon, and carbon dioxide are cryogens in cryotherapy systems. These cryogenic gases serve as coolants to reach extremely low temperatures to perform cryotherapy. A loss of consciousness may occur at extremely low cryogenic temperatures. In the years to come, the cryotherapy business may face challenges, and one of the potential reasons for this is expected to be the dangerous effects of cryogenic gases used in several cryosurgery equipment and cryochambers.
Ablation Technology Market Ecosystem
By technology, the radiofrequency ablation segment accounted for the largest market share of the ablation technology industry 2023.
Based on technology, the ablation technology market is segmented into radiofrequency ablation, laser/light ablation, ultrasound ablation, electrical ablation, cryoablation, microwave ablation, pulsed-field ablation, and hydrothermal/hydromechanical ablation. The increasing use of radiofrequency ablation in aesthetic surgeries, proven safety, and long-term efficacy of the technology drives segment growth. Radiofrequency ablation for aesthetic treatments, such as wrinkle reduction and body contouring, also contributes to market growth due to the rising demand for non-surgical treatments globally across all age groups.
By product, the consumables segment accounted for the largest market share of the ablation technology industry in 2023.
Based on product, the ablation technology market is segmented into systems and consumables. In 2023, the consumables segment accounted for the largest market share. A surge in oncological surgeries, the development of multi-electrode catheters, and the rising emphasis on ablation treatment to treat various complications such as atrial fibrillation contribute to the increasing adoption of ablation systems. Consumables are single-use devices and should be replaced for every new patient; this contributes to the recurring revenue of the company and is expected to propel market growth.
By application, the cardiovascular disease treatment segment held the largest market share of the ablation technology industry in 2023.
Based on application, the ablation technology market is segmented into cardiovascular disease treatment, cancer treatment, orthopedic treatment, cosmetic/aesthetic surgery, urological treatment, gynecological segment, pain management, ophthalmology treatment, and other applications. The cardiovascular disease treatment segment held the largest market share in 2023. The cosmetic /aesthetic surgery segment is expected to grow significantly from 2024 to 2029. Factors such as proven improved safety in clinical studies and enhanced health promotion campaigns to raise awareness related to early diagnosis drive segment growth.
By end user, the hospitals, surgical centers, and ablation centers segment commanded the largest market share of the ablation technology industry.
Based on end users, the ablation technology market is segmented into hospitals, surgical centers, and ablation centers; ambulatory surgery centers; medical spas and dermatology & aesthetic clinics. And other end users., The ambulatory surgery centers are expected to grow at the highest CAGR during the study period. The rising prevalence of chronic illness, cost-effectiveness, and the potential benefits of ablation observed in patients with early-stage cancer have contributed to the segment growth.
By region, North America is expected to be the largest market in the global ablation technology industry by 2029.
The US accounted for a significant share of the North American ablation technology market in 2023. The noticeable growth of the regional market is due to its technological leadership, advanced healthcare infrastructure, favorable insurance coverage, increased funding and grants for developing advanced medical equipment, strategic research collaborations, and a supportive market environment fostering innovation. Also, the presence of major players, strategic acquisitions, growing preference for non-surgical solutions, and increasing number of awareness programs further contribute to the market growth.
To know about the assumptions considered for the study, download the pdf brochure
As of 2023, prominent players in the market are Johnson & Johnson (US), Medtronic (US), Boston Scientific Corporation (US), Abbott (US), and Atricure, Inc. (US).
Scope of the Ablation Technology Industry:
|
Report Metric |
Details |
|
Market Revenue in 2024 |
$6.11 billion |
|
Projected Revenue by 2029 |
$9.62 billion |
|
Revenue Rate |
Poised to Grow at a CAGR of 10.4% |
|
Market Driver |
Emerging ablation technologies |
|
Market Opportunity |
Growth potential in emerging economies |
This report has segmented the global ablation technology market based on technology, product, application, end user, and region.
By Technology
- Radiofrequency ablation
- Laser/Light Ablation
- Ultrasound Ablation
- Electrical Ablation
- Cryoablation
- Microwave Ablation
- Pulsed field Ablation
- Hydrothermal/Hydromechanical Ablation
By Product
- Systems
- Consumables
- Global Ablation Technology Market, By Application
- Cardiovascular Disease Treatment
- Cancer Treatment
- Ophthalmological Treatment
- Pain Management
- Gynecological Treatment
- Urological Treatment
- Orthopedic Treatment
- Cosmetic/ Aesthetic Surgery
- Other Treatments
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
-
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia Pacific
-
Latin America
- Brazil
- Mexico
- Rest of Latin America
Recent Developments of Ablation Technology Industry
- In February 2024, Johnson & Johnson (US) received CE mark approval for the VARIPULSE Pulse Field Ablation Platform that helps visualize real-time and enhances workflow.
- In December 2023, Medtronic (US) approved a Pulse Select Pulsed Field Ablation System that helps treat persistent and paroxysmal atrial fibrillation.
Frequently Asked Questions (FAQ):
What is the expected addressable market value of the global ablation technology market over six years?
The global ablation technology market is expected to reach USD 9.62 billion by 2029 from USD 6.11 billion in 2024, at a CAGR of 9.5% from 2024 to 2029.
Which segment based on product is expected to garner the highest traction within the ablation technology market?
Based on the product, the consumables segment is expected to grow at the highest rate. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the ablation technology market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Primary research was conducted after acquiring extensive knowledge about the global ablation technology market scenario through secondary research. Primary interviews were conducted with market experts from both the demand-side (such as hospitals, research universities, academic institutions, and government institutions, among others) and supply-side respondents (such as presidents, CEOs, vice presidents, directors, general managers, heads of business units, and senior managers) across five major geographies, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East, and Africa. Approximately 30% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 70%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.
A breakdown of the primary respondents is provided below:
To know about the assumptions considered for the study, download the pdf brochure
Market Estimation Methodology
A detailed market estimation approach was followed to estimate and validate the size of the global ablation technology market and other dependent submarkets.
- Key players in the global ablation technology market were identified through secondary research, and their global market shares were determined through primary and secondary research.
- The research methodology included the study of the annual and quarterly financial reports & regulatory filings of major market players as well as interviews with industry experts (such as CEOs, VPs, directors, and marketing executives) for detailed insights (both qualitative and quantitative trends) on the ablation technology market.
- All percentage shares, splits, and breakdowns for the global ablation technology market were determined by using secondary sources and verified through primary sources.
- All the key macro indicators affecting the revenue growth of the market segments and sub-segments have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the validated and verified quantitative & qualitative data.
- The gathered market data was consolidated and added to detailed inputs, analyzed, and presented in this report.
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
Data Triangulation:
After arriving at the overall size of the global ablation technology market through the above-mentioned methodology, this market was split into several segments and sub-segments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and sub-segments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both the demand- and supply-side participants.
Report Objectives:
- To define, describe, and forecast the ablation technology market based on type, product, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the global ablation technology market (such as drivers, restraints, challenges, opportunities, and regulatory landscape, among others)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global ablation technology market
- To analyze the opportunities in the global ablation technology market for stakeholders and provide details of the competitive landscape for market leaders
- To profile key global players and comprehensively analyze their market shares and core competencies
- To provide a five-year forecast for various market segments in terms of revenue with respect to five main regions, namely, North America (includes the US and Canada), Europe (includes Germany, the UK, France, Italy, and Spain), Asia Pacific (includes Japan, China, India, Australia, and South Korea), Latin America (includes Brazil and Mexico), and the Middle East & Africa
- To track and analyze competitive developments such as product launches; expansions, and mergers and acquisitions; and research and development activities in the ablation technology market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the global ablation technology market report:
Product analysis
- Product matrix, which gives a detailed comparison of the product portfolios of the top five companies
Company information
- Detailed analysis and profiling of additional market players (up to five)
Geographic analysis
- Further breakdown of the Rest of Europe ablation technology market into Belgium, Austria, Denmark, Greece, Poland, and Russia, among other countries
- Further breakdown of the Rest of Asia Pacific ablation technology market into New Zealand, Vietnam, Philippines, Singapore, Malaysia, Thailand, and Indonesia, among other countries
- Further breakdown of the Rest of Latin America ablation technology market into Argentina and Colombia, among other countries
Top players operating in Ablation systems Market
- Abbott Laboratories
- AngioDynamics Inc.
- AtriCure Inc.
- Biosense Webster Inc. (Johnson & Johnson)
- Boston Scientific Corporation
- CONMED Corporation
- Medtronic plc
- Olympus Corporation
- Smith & Nephew plc
- Varian Medical Systems Inc.
Niche growth drivers for Ablation systems Market
Growing demand for minimally invasive procedures: Ablation procedures are minimally invasive and have the potential to reduce recovery time and hospital stays. As a result, there is growing demand for ablation procedures, which is expected to drive the growth of the ablation systems market.
Increasing prevalence of chronic diseases: Ablation systems are used to treat various chronic diseases such as atrial fibrillation, cancer, and chronic pain. As the prevalence of these diseases continues to rise, the demand for ablation systems is also expected to increase.
Technological advancements in ablation systems: Advancements in ablation systems, such as the development of new ablation catheters, are expected to drive the growth of the ablation systems market. New technologies have the potential to improve the efficacy of ablation procedures and make them more accessible to patients.
Rising geriatric population: The aging population is at a higher risk of developing chronic diseases that require ablation procedures. As the geriatric population continues to grow, the demand for ablation systems is expected to increase.
Increasing investments in healthcare infrastructure: Governments and private organizations are investing in healthcare infrastructure, including the development of new hospitals and clinics. This is expected to increase the availability of ablation systems and drive the growth of the market.
Rising demand for cosmetic procedures: Ablation systems are also used in cosmetic procedures such as laser hair removal and skin rejuvenation. As the demand for cosmetic procedures continues to rise, the demand for ablation systems is also expected to increase.
Future Ablation systems Market trends
Increased use of robotic-assisted ablation: Robotic-assisted ablation allows for greater precision and control during procedures, which may improve patient outcomes. As a result, the use of robotic-assisted ablation is expected to increase in the future.
Expansion into emerging markets: As healthcare infrastructure improves in emerging markets, there is expected to be increased demand for ablation systems. As a result, companies may expand their operations into these markets to take advantage of the growing demand.
Development of new ablation techniques: There is ongoing research into new ablation techniques that may be more effective and have fewer side effects than current techniques. As these new techniques are developed and approved, they may drive the growth of the ablation systems market.
Growing demand for image-guided ablation: Image-guided ablation allows for greater accuracy during procedures, which may improve patient outcomes. As a result, there is expected to be increased demand for image-guided ablation in the future.
Adoption of disposable ablation devices: Disposable ablation devices are more convenient and may reduce the risk of infection during procedures. As a result, there is expected to be increased adoption of disposable ablation devices in the future.
Increasing focus on outpatient procedures: Ablation procedures can be performed on an outpatient basis, which may reduce healthcare costs and improve patient satisfaction. As a result, there is expected to be an increasing focus on performing ablation procedures in outpatient settings.
Future hypothetic growth opportunity for Ablation systems Market
One potential future growth opportunity for the Ablation Systems Market is the development of new indications for ablation therapy. Ablation therapy is currently used to treat a variety of conditions, including cancer, atrial fibrillation, and chronic pain. However, there may be new indications for ablation therapy that have not yet been explored.
For example, there is ongoing research into the use of ablation therapy to treat psychiatric disorders such as depression and obsessive-compulsive disorder. If these new indications are proven effective and approved by regulatory agencies, it could drive significant growth in the ablation systems market.
Another potential growth opportunity is the development of new ablation technologies that are more effective and have fewer side effects than current technologies. As research in this area continues, new ablation technologies may be developed that can treat a wider range of conditions and improve patient outcomes.
Finally, the continued expansion of healthcare infrastructure in emerging markets could also drive growth in the ablation systems market. As access to healthcare improves in these markets, there is likely to be increased demand for ablation therapy, which could create new growth opportunities for companies operating in the market.
Niche threats/restraints for Ablation systems Market in enterprise
High cost: Ablation systems can be expensive, and this may limit their adoption in certain markets. Hospitals and healthcare providers may be hesitant to invest in expensive equipment, especially if they are unsure about the long-term return on investment.
Competition from alternative therapies: Ablation therapy competes with other therapies, including surgery and radiation therapy. The availability of alternative therapies may limit the adoption of ablation systems, particularly in cases where these alternative therapies are proven effective.
Regulatory hurdles: The regulatory environment for ablation systems is complex and constantly evolving. Companies operating in the market may face challenges obtaining regulatory approval for new products or expanding into new markets.
Limited reimbursement: The availability of reimbursement for ablation therapy varies by region and may limit the adoption of these systems. In some markets, reimbursement for ablation therapy may be limited, which could impact the willingness of hospitals and healthcare providers to invest in these systems.
Limited clinical evidence: Despite the growing use of ablation therapy, there is still limited clinical evidence supporting its effectiveness for certain conditions. The lack of robust clinical evidence may limit the adoption of these systems, particularly in cases where other therapies have established clinical evidence.
Generating Response ...
Growth opportunities and latent adjacency in Ablation Technology Market
Looking information on ablation technology market growth to invest
Detailed US geo analysis of Ablation Technology Market - Forecast 2022 to 2030.